{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:12:12Z","timestamp":1782853932313,"version":"3.54.5"},"reference-count":10,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/100015003","name":"ACT Government","doi-asserted-by":"publisher","award":["ACT GOV 09062022"],"award-info":[{"award-number":["ACT GOV 09062022"]}],"id":[{"id":"10.13039\/100015003","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canberra Hospital Private Practice Fund","award":["TCHPPF21062022"],"award-info":[{"award-number":["TCHPPF21062022"]}]},{"name":"Australian Government Research Training Program Scholarship","award":["00465206"],"award-info":[{"award-number":["00465206"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>People who report sexual assault express concerns regarding contracting sexually transmitted infection (STI); however, published literature regarding the risk of STI transmission in this context is sparse.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>We audited STI and blood-borne virus (BBV) testing at a forensic and medical sexual assault care service in the Australian Capital Territory between 2004 and 2022. Eligibility for testing among 1928 presentations was defined based on risk (eg, reported penetration). Testing at presentation included chlamydia and gonorrhoea 1850, syphilis and BBV 1472, and after 2\u20136 weeks, 890 out of 1928 (46.2%) and after 3 months 881 out of 1928 (45.7%), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At presentation, 100 out of 1928 (5.2%) individuals were diagnosed with chlamydia, of those, 95 out of 1799 (5.3%) were female, and 5 out of 121 (4.1%) were male. Gonorrhoea was diagnosed in 7 out of 1920 (0.4%), 5 out of 95 female and 2 out of 5 male. Hepatitis B, which was all pre-existing, was diagnosed in 5 out of 1799 (0.3%). Overall, chlamydia prophylaxis was given to 203 out of 1928 (10.5%) and HIV post-exposure prophylaxis to 141 out of 1928 (7.3%).<\/jats:p><jats:p>At 2\u20136 weeks of follow-up, 10 out of 890 (1.1%) individuals were diagnosed with chlamydia, with no gonorrhoea diagnosed. There were no cases of syphilis, hepatitis B or HIV diagnosed at 3-month serology testing in 881 individuals. Chlamydia detection at follow-up was more common in the group aged 15\u201329 years. Of those provided with chlamydia prophylaxis, 203 out of 1928, only 16 out of 203 (7.9%) were diagnosed with chlamydia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The offer of STI testing is almost universally accepted by individuals presenting for post-sexual assault care. There were no identifiable factors to justify the routine use of chlamydia prophylaxis. STI testing provided an opportunity for screening and should remain part of the clinical care of people who report sexual assault.<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2023-055944","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T18:20:40Z","timestamp":1701541240000},"page":"45-47","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Sexually transmitted infections diagnosed in individuals presenting for forensic and medical care following sexual assault"],"prefix":"10.1136","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5274-4915","authenticated-orcid":false,"given":"Vanita R","family":"Parekh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Tyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Brkic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"McMinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Beaumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis J","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,2]]},"reference":[{"key":"2024021320200851000_100.1.45.1","unstructured":"Kilpatrick DG , Edmunds CN , Seymour A . Rape in America: a report to the nation. Charleston: Medical School University of South Carolina, National Individual Center and Crime Individuals Research and Treatment Center, 1992."},{"key":"2024021320200851000_100.1.45.2","unstructured":"World Health Organisation . Sexually transmitted infections (STIs). 2023. Available: https:\/\/who.int OR https:\/\/www.who.int\/health-topics\/sexually-transmitted-infections#tab=tab_1 [Accessed 20 Sep 2023]."},{"key":"2024021320200851000_100.1.45.3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1071\/SH22134","article-title":"Australian sexually transmitted infection (STI) management guidelines for use in primary care 2022 update","volume":"20","author":"Ong","year":"2023","journal-title":"Sex Health"},{"key":"2024021320200851000_100.1.45.4","unstructured":"Post-Exposure Prophylaxis (PEP) . Post-exposure prophylaxis after occupational and non-occupational exposure to HIV. Australian National Guidelines (third edition). 2023. Available: https:\/\/www.pep.guidelines.org.au\/ [Accessed 20 Sep 2023]."},{"key":"2024021320200851000_100.1.45.5","unstructured":"King J , McManus H , Gray R , et al . HIV, viral hepatitis, and sexually transmissible infections in Australia: Annual surveillance report 2022. Sydney, Australia: The Kirby Institute, UNSW Sydney, 2022. Available: http:\/\/doi.org\/10.26190\/sx44-5366"},{"key":"2024021320200851000_100.1.45.6","unstructured":"4102.0 - Australian social trends. 2012. Available: abs.gov.au [Accessed 15 May 2023]."},{"key":"2024021320200851000_100.1.45.7","unstructured":"Sexual assault and abuse and Stis \u2013 adolescents and adults. 2021. Available: https:\/\/www.cdc.gov\/std\/treatment-guidelines\/sexual-assault-adults.htm"},{"key":"2024021320200851000_100.1.45.8","doi-asserted-by":"publisher","DOI":"10.1177\/2042098614554919"},{"key":"2024021320200851000_100.1.45.9","doi-asserted-by":"crossref","unstructured":"Skj\u00e6laaen K , Nesvold H , Brekke M , et al . Sexually transmitted infections among individuals attending a sexual assault centre: a cohort study from Oslo, Norway. BMJ Open 2022;12:e064934. doi:10.1136\/bmjopen-2022-064934","DOI":"10.1136\/bmjopen-2022-064934"},{"key":"2024021320200851000_100.1.45.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(98)70361-8"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2023-055944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T04:21:21Z","timestamp":1707884481000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2023-055944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,2]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,17]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/sextrans-2023-055944"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2023-055944","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,2]]}}}